Q1 2026 was operationally a step forward on multiple fronts: new long-term data from NXTCL-T1D reinf...
Redeye states that the Q1 2026 report came in below estimates on net sales, with both Wireless and P...
The CMD was titled "Best-built for winning future retail".
With key catalysts due over the next seven months, including in Q2 with preliminary glioblastoma (GB...
Magle has announced a new loan facility agreement with existing bondholders, providing up to SEK60m ...
Redeye provides an update following AcouSort’s Q1 2026 report, which showed revenue and EBIT largely...
Redeye provides an update on Saniona after the company's Q1 report, which offered few surprises.
New peer-reviewed data from the Phase III PEARL study (GEICAM/2013-02) published in the European Jou...
XP Chemistries har under våren avslutat ett lyckat "proof of concept"-test med den anlitade kontrakt...
Yesterday, LION announced its first delivery of BESS containers to Finsterwalde (Eastern Germany).
Redeye comments on Fluoguide’s Q1 2026 report. The quarter was marked by two consecutive FDA decisio...
InvesteraMera lämnar en kort kommentar på de övergripande data som presenterades från den europeiska...
Redeye comments on the recent press releases from Enviro, which highlight operational progress, secu...
Redeye comments on SynAct Pharma's Q1 report. The main event since our Q4 update was the directed sh...
Cereno Scientific has announced that its third asset, CS585 (a potent and selective agonist of the p...
Yesterday, learnd SE published a Q1 trading update for its equity stake (49.
Oncopeptides has announced an exclusive distribution and commercialization agreement with Salus for ...
We found the CMD informative of BONESUPPORT’s ongoing clinical study pipeline, spinal fusion indicat...
At 3GPP RAN4#119 in Dalian in May 2026, the working group agreed to study digital beamforming for 6G...
Under kvartalet fortsatte QBIM utvecklingen av Q-Sales och genomförde omfattande produktinvesteringa...